The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Hi JR
I didn’t say true value was 40p, just that was the IPO price
Personally i think fair value is higher than that
Imho
Good luck
Just grabbed some before close, if true value is in fact 40p then happy to hold up to those levels for a short period.
Totally agree mike
Ive just watched it for the second time
A fantastic opportunity, i think the IPO was at 40p
Crazy low price considering where they are with roll out
Imho
I've just seen the video and I've rarely seen one like it. I couldn't find fault in any of it and the enthusiasm of Marla was quite infectious. Not surprised the SP has responded thus. I don't where the SP is going but it's going to be multiple.
Just reviewed the Presentation
total Market in the USA ( Canada has been given approval as well) 33,000,000 in Both Irritable Bowel Diseases and Irritable Bowel Syndrom- break even for the company 7,000 patients or 0.021% of the market!!!!
Contracts signed
Crohns and Collitis Foundation- exclusive deal to offer the App via the Foundation's website and endorsed by the Foundation
Exclusive Deal with the American College of Gastroenterologists to offer the app through the 16,000 Pratitioners of the college to their patients.
2 of the largest Health Insurance providers in final stage discussions to provide the app to their members with GI conditions.
Approached by Large Pharma to assist in running Phase 2 and Phase 3 trials for GI medication.
Mount Sinai Hospital signed up to provide the app to its Staff.
New Yor Medicaid provider contract signed.
New York labour Union signed up to provide App to its members with GI conditions.
Targeting 50% market share!!!!
NT to buy small amounts and medium amounts over ask, makes sense
I wonder what PR they have in the states? If the market here is to sleepy to wake up to this im sure our American cousins would see the value.
Marla smashed that interview yesterday. This is an easy buy even if the company was doing nothing simply because of the disconnect between cash and sp, but WITH promising newsflow, like you said it's lunacy but I. Thankful the market throws up opportunities like this from time to time
Double digits first would be nice, still not even equal to cash position, utter lunacy, that presentation needs to be diseminated to a wider audience. They all expressed their dismay at the share price, it wont realise its potential without some drum banging, hopefully one or two of those big pharma and insurance company deals gets RNSd soon. 65p all time high this year shows whats possible.
A 'sensible' SP of 30p and could easily go higher with sentiment and greed. A fun few days ahead for sure
End of day share price rocket, will be interesting to see what the SP opens at tomorrow.
In final talks with 2 large healthcare groups, I wonder who they could be?
Totally agree djm1
As it takes off it should snowball quickly
Tivman,
it was agood watch, by virtue of Marla's profffessional standing shes basically made the App available to 100% of the market via the two main proffesssional Gastrointestinal Bodies in the USA, which are endorsing it for people with GI conditions, you can see the big medical insurance companies pushing this hard as it will reduce their outlays significantly for reactive medical treatments and procedures. Might not get insured unless you agree to follow the app protocols going forward.
Enjoy it Mike.
https://www.investormeetcompany.com/
You can watch it here
Need to register
Still can't find the link. Been all over the website and, despite djm1's help, I can't find the presentation.
Have to say that was the best presentation I’ve seen
Very exciting future
Very Impressive, so undervalued, endorsed by the two most significant Gastro Intestinal Medical bodies in the US with exclusive agreements to help their memebers and doctors with big contracts coming on line. Only need a tiny fraction of the addressable market to break even. The two Gastro Intestinal organisations will access all of the adressable market.
3.30 monday, live, link address bottom of RNS
Bit out of the loop with this one. Is the presentation live, written or recorded? Any help please.
Seems some cant wait till Monday, they were hoping for a bag today, when the forward plans are fleshed out on Monday some sense should hopefully prevail.
Totally agree
Looking forward to the presentation
It wont take much to move this up
Imho
Goodness me. A RNS that points to good progress, plenty of late stage negotiations with health insurance companies and providers, acceleration of commercialisation, funds to take them in to 2025, general acceptance as a new approach in healthcare and the SP dips nearly 10%.
Crazy world.
Looks like rerate will have to wait till after Monday's presentation, it will be on a few more people's radar then, everyone loves a bargain.
Mkt cap £12.5m
Cash £21.5m
You would say the share price ought to be a bag or 3 higher here.